Clinical Trials Directory

Trials / Conditions / Lymphoma, Large-Cell, Diffuse

Lymphoma, Large-Cell, Diffuse

18 registered clinical trials studyying Lymphoma, Large-Cell, Diffuse — 1 currently recruiting.

StatusTrialSponsorPhase
Enrolling By InvitationA Multicenter, Prospective, Randomized, Controlled Study of Decitabine in Combination With R-CHOP for Initial
NCT07348575
Second Affiliated Hospital of Nanchang UniversityPhase 3
CompletedOfatumumab Versus Rituximab Salvage Chemoimmunotherapy Followed by Autologous Stem Cell Transplant in Relapsed
NCT01014208
GlaxoSmithKlinePhase 3
CompletedPhase II Study of Ofatumumab Plus Ifosfamide, Carboplatin, Etoposide (ICE) or Dexamethasone, Cytarabine, Cispl
NCT00823719
GlaxoSmithKlinePhase 2
CompletedOfatumumab in Patients With Relapsed/Progressive Diffused Large B-Cell Lymphoma (DLBCL) Ineligible for or Rela
NCT00622388
GlaxoSmithKlinePhase 2
CompletedCT-011 MAb in DLBCL Patients Following ASCT
NCT00532259
CureTech LtdPhase 2
CompletedTargeted Intensification With ZBEAM and Autologous Stem Cell Transplantation in Patients With High-grade B-Cel
NCT00689169
Lymphoma Study AssociationPhase 2
CompletedA Study of Two Associations of Rituximab and Chemotherapy, With a PET-driven Strategy, in Lymphoma
NCT00498043
Hospices Civils de LyonPhase 2
TerminatedStudy of YM155 in Refractory Diffuse Large B-cell Lymphoma (DLBCL) Subjects
NCT00498914
Astellas Pharma IncPhase 2
CompletedChemotherapy for Participants With Lymphoma
NCT00436280
Eli Lilly and CompanyPhase 2
CompletedBortezomib Plus CHOP Every 2 Weeks for Advanced Stage DLBCL
NCT00379574
Asan Medical CenterPhase 1 / Phase 2
TerminatedStudy Comparing Zevalin Regimen With no Further Treatment in Patients With Diffuse Large B-cell Lymphoma.
NCT00322218
Spectrum Pharmaceuticals, IncPhase 3
TerminatedPTK787 in Refractory or Relapsed Diffuse Large Cell Lymphoma
NCT00511043
David Rizzieri, MDPhase 2
CompletedDiffuse Large B Cell Lymphoma of the Adult: Randomization Between High Dose Chemotherapy With Rituximab and CH
NCT00561379
Nantes University HospitalN/A
CompletedR-ICE Versus R-DHAP in Patients Aged 18-65 With Relapse Diffuse Large B-cell Lymphoma
NCT00137995
Lymphoma Study AssociationPhase 3
TerminatedPilot Study of Umbilical Cord Blood Transplantation in Adult Patient With Advanced Hematopoietic Malignancies
NCT00514722
University of California, San FranciscoN/A
TerminatedR-ACVBP Versus R-CHOP in Patients Aged 60-65 With Diffuse Large B-cell Lymphoma
NCT00135499
Lymphoma Study AssociationPhase 3
CompletedACVBP Followed by ASCT in Patients With BCL-2 Positive Diffuse Large B-Cell Lymphoma
NCT00169130
Lymphoma Study AssociationPhase 2 / Phase 3
CompletedPilot Protocol for the Treatment of Patients With Small Non-Cleaved and Diffuse Large Cell Lymphomas
NCT00001237
National Cancer Institute (NCI)Phase 2